Aclarion sees net loss but strengthens cash position

▤ Summary

Aclarion posted a wider net loss of $2.85 million for the quarter ended March 31, up from $2.04 million, while revenue rose to $21,140 from $18,991 driven by increased Nociscan reports sold in the U.K. Operating expenses nearly doubled to $2.99 million. Cash, cash equivalents and restricted cash increased to $19.03 million after a January direct offering that generated about $10.4 million in gross proceeds, and the company announced a share-repurchase program of up to $2.5 million to be executed over the next 12 months. At least three directors bought shares this week, while the stock remains roughly 75% below its 52-week high and closed at $3.22.

▦ Linked Companies

Aclarion

up to $1M